Last updated on April 2019

A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Patients With Knee Osteoarthritis

Brief description of study

This study is a phase 2, 52-week international, multi-regional, multicenter, randomized, double-blind, placebo-controlled dose-ranging study for the treatment of Osteoarthritis.

Clinical Study Identifier: NCT03595618

Contact Investigators or Research Sites near you

Start Over

Phoenix Medical Reasearch

Prairie Village, KS United States
  Connect »

University of Kansas Medical Center

Kansas City, KS United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.